Spectrum Pharmaceuticals (SPPI +4.6%) finishes the day higher after saying late yesterday that...

|About: Spectrum Pharmaceuticals, Inc. (SPPI)|By:, SA News Editor

Spectrum Pharmaceuticals (SPPI +4.6%) finishes the day higher after saying late yesterday that safety findings from its Phase 2 trial of belinostat showed an acceptable profile in patients with relapsed T-cell lymphoma.